HomeHealthCNS disease: being small in size is not always better -...

CNS disease: being small in size is not always better – ESMO 2012


Evandro de Azambuja and Matthias Preusser describe results of the CEREBEL trial looking into future implications for the treatment of brain metastases. This study was presented during ESMO 2012, the Congress of the European Society for Medical Oncology. Read all the news about the latest in cancer and oncology from the Congress here:

The opinion expressed in this interview reflects that of the interviewee and does not necessarily express the official ESMO point of view.

Video produced by the European Society for Medical Oncology (ESMO)

source

Must Read
- Advertisement -Микроигольчатый RF в Киеве
- Advertisement -клиника лазерной и клеточной медицины киев
- Advertisement -спа киев
Related News